The biggest marriage in the drug industry’s history hasn’t provided the type of booster shot to shares of deal participants Pfizer and Allergan, nor has the merger provided a major lift to shares of other big pharma names. If there’s been any semblance of steroid-like reaction, it was been in biotech stocks, which were solidly in the black Monday.
Not even the announcement of a record-breaking deal valued at roughly $160 billion could push shares of American drug maker Pfizer (maker of Viagra) and Irish-based Allergan (maker of Botox) higher Monday. Pfizer’s (PFE) stock fell 85 cents, or 2.6%, to $31.33 Monday. And even though Pfizer is offer...
18:53 Trade Grades: Mavs Steal Nerlens Noel From 76ers In Savvy Deadline Move19
01:22 Lakers reportedly trade Lou Williams to Rockets in first deal of Magic Johnson era13
22:43 Kings GM on Cousins trade: I had a better deal two days ago11
17:58 Kraft Heinz drops Unilever takeover bid22